Utrecht, Netherlands

Cornelis Jacob Johannes George Bol

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Cornelis Jacob Johannes George Bol

Introduction

Cornelis Jacob Johannes George Bol is a prominent inventor based in Utrecht, Netherlands, known for his significant contributions to the field of medical treatments. Bol has developed a pioneering approach to targeting certain cancers, demonstrating the potential of bispecific antibodies in therapeutic applications.

Latest Patents

Bol holds a patent for "CLEC12AxCD3 bispecific antibodies and methods for the treatment of disease." This innovative patent specifically addresses the treatment of CLEC12A positive cancers. The methodology disclosed involves administering bispecific antibodies that bind both CD3 and CLEC12A. The treatment consists of multiple administrations, progressively increasing the dosage of the bispecific antibodies, thereby improving the therapeutic efficacy while sparing normal CLEC12A positive hematopoietic cells. This pioneering approach could revolutionize treatment protocols by allowing for recovery of normal cells during cancer treatment.

Career Highlights

Bol is associated with Merus N.V., a company that focuses on developing innovative therapeutics based on bispecific antibody technology. His work exemplifies the intersection of innovation and practical application in the medical field, focusing on the treatment of challenging cancers through advanced scientific methods.

Collaborations

Throughout his career, Bol has collaborated with notable colleagues, including Alexander Berthold Hendrik Bakker and Pieter Fokko Van Loo. Their combined expertise in the biotechnology sector enhances the quality and effectiveness of their research, contributing to advancements in cancer treatment.

Conclusion

Cornelis Jacob Johannes George Bol exemplifies the innovative spirit of modern inventors in the healthcare sector. His contributions through patents not only enhance the understanding of bispecific antibodies but also pave the way for more effective treatment strategies for patients battling CLEC12A positive cancers. As the landscape of medical innovation continues to evolve, the work of inventors like Bol remains pivotal in shaping the future of therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…